Cigna Group (NYSE:CI – Get Free Report) insider Nicole Jones sold 2,677 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the sale, the insider directly owned 25,880 shares in the company, valued at $7,236,306.80. The trade was a 9.37% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Cigna Group Stock Performance
Shares of NYSE:CI traded down $2.95 during trading on Thursday, hitting $274.50. 1,088,093 shares of the stock traded hands, compared to its average volume of 1,696,515. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The company has a fifty day moving average price of $285.03 and a two-hundred day moving average price of $281.41. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a market cap of $72.53 billion, a price-to-earnings ratio of 11.36, a P/E/G ratio of 0.96 and a beta of 0.29.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts predict that Cigna Group will post 30.51 EPS for the current year.
Cigna Group Announces Dividend
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Wilkerson Advisory Group LLC purchased a new stake in Cigna Group during the 4th quarter worth approximately $25,000. Osbon Capital Management LLC purchased a new position in shares of Cigna Group in the second quarter valued at approximately $26,000. Cedar Mountain Advisors LLC boosted its stake in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after acquiring an additional 68 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Cigna Group during the second quarter worth approximately $29,000. Finally, Fiduciary Financial Advisors purchased a new stake in shares of Cigna Group during the second quarter worth approximately $29,000. 86.99% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
CI has been the subject of several recent analyst reports. Sanford C. Bernstein lifted their price target on Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Morgan Stanley raised their price objective on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Mizuho boosted their price objective on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Jefferies Financial Group downgraded Cigna Group from a “buy” rating to a “hold” rating and reduced their target price for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Finally, Guggenheim increased their target price on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $339.45.
Get Our Latest Stock Analysis on CI
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
